The national drug price regulator National Pharmaceutical Pricing Authority (NPPA) has recovered more than Rs 35 crore in the first nine months of the current financial year from the companies for overcharging drug prices, as against the recovery of more than Rs 50 crore in the last fiscal.
With this, the authority has recovered nearly Rs 200 crore out of the total due amount of almost Rs 2100 crore from the pharmaceutical firms in the country, informs S M Jharwal, chairman, NPPA. However, the details of the firms which had paid the overcharging dues is yet to be known.
According to the information furnished by the NPPA with the panel, earlier in 2009, the total number of cases also includes 76 cases where the demand has been contested by the company in courts of law and 14 cases referred to collector concerned for recovery but subsequently contested by the companies in courts of law.
